STING1 and neoplasm: It was also reported that STING‐activating nano‐vaccines delivering tumor neo‐antigens could effectuate intense and persistent antigen‐specific T‐cell responses, which were followed by vigorous immunotherapeutic efficacy in numerous murine cancer models.35, 36